Poland

Bloodstream infections with resistant bacteria in Poland are rising far faster than in the EU

In Poland, the frequency of bloodstream infections caused by Klebsiella pneumoniae resistant to last-resort antibiotics has nearly quintupled since 2019, according to ECDC data for 2025. Across the European Union, the increase was 72%.

The European Centre for Disease Prevention and Control (ECDC) published the data to mark European Antibiotic Awareness Day, observed on 18 November. The agency warns that Europe remains far from the targets set for 2030. Bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae – a class of antibiotics reserved for severe infections – are associated with a high risk of death. Details are in the ECDC statement.

Poland: from 1.38 to 6.81 cases per 100,000 inhabitants

According to data for 2019–2025, the frequency of such infections in the EU rose by 72%, although it was supposed to fall by 5% by 2030. In Poland, the increase was 393% – from 1.38 to 6.81 cases per 100,000 inhabitants.

The situation with Escherichia coli resistant to third-generation cephalosporins is also worse than expected. In the EU, the frequency of bloodstream infections rose by 16.4%, instead of falling by 10%. In Poland, the increase was 31.3%. ECDC also points to the growing detection of E. coli resistant to carbapenems – not only in hospitals but also outside them.

MRSA: target met in the EU, not in Poland

Infections with methicillin-resistant Staphylococcus aureus (MRSA) fell by 19% in the EU since 2019, meeting the EU target. However, the agency notes that increases over the last two years threaten this progress. In Poland, the decline was only 0.2%, against a planned reduction of 10%.

Antibiotic use is falling too slowly

Total antibiotic consumption in the EU in 2025 was 5% lower than in 2019; by 2030 it should fall by 20%. In Poland, it decreased by 6.9% – from 23.6 to 22 defined daily doses per 1,000 inhabitants per day – against a national reduction target of 27%.

The WHO recommends that at least 65% of consumption consist of Access group antibiotics, meaning first-choice antibiotics with a lower potential to drive resistance. In Poland, their share fell from 60.4% to 57.1% since 2019.

The scale of the problem and ECDC’s appeal

In the EU, more than 35,000 people die each year from infections caused by drug-resistant microbes. Around 4.3 million patients in the EU and EEA contract infections during hospital stays, and according to ECDC, half of these infections could be prevented with more effective control.

ECDC Director Pamela Rendi-Wagner stressed that Europe is far from achieving many targets concerning antimicrobial resistance, while new monitoring methods allow faster responses to threats. The agency calls on countries to strengthen infection control in healthcare facilities, use antibiotics responsibly, and develop diagnostics and epidemiological surveillance. This year’s campaign focuses on children, under the slogan “Take care of your children – use antibiotics wisely”. ECDC reminds that colds, coughs and sore throats are usually caused by viruses, which antibiotics do not work against.

Dorota Lune

Dorota Lune, redaktorka serwisu DigitalNexus.pl. Zajmuje się tematyką show-biznesową, bieżącymi informacjami jak i ciekawostkami ze świata. Ukończyła dziennikarstwo na UPJPII w Krakowie. Wcześniej pracowała w branży turystycznej. W wolnych chwilach lubi podróżować i czytać książki.